Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Sierra, J M ^a   Ortega, M ^a   Tarrago C ^a   Albet, C ^a   Vila, J ^b   Terencio, J ^a   Guglietta, A ^a  

^a Ferrer International SA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Accumulation; Antimicrobial resistance; Oxazolidinones; Staphylococci

Indexed keywords

AGAR; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; LINEZOLID; OXACILLIN; RESERPINE; RIFAMPICIN; RNA 23S; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL DNA; OXAZOLIDINONE DERIVATIVE; RIBOSOME DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RNA SEQUENCE; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET RADIATION; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; GENETIC SELECTION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MUTATION; NUCLEOTIDE SEQUENCE; TRANSPORT AT THE CELLULAR LEVEL; VIRUS CULTURE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; OXAZOLIDINONES; RNA, RIBOSOMAL, 23S; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 73949109711     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp309     Document Type: Article

References (10)

1. Bozdogan B, Appelbaum PC. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 2004; 23: 113-9.
2. Marshall SH, Donskey CJ, Hutton-Thomas R et al. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46: 3334-6.
3. Mendes RE, Deshpande LM, Castanheira M et al. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008; 52: 2244-6.
4. Arias CA, Vallejo M, Reyes J et al. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 2008; 46: 892-6.
5. Escribano I, Rodriguez JC, Llorca B et al. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 2007; 53: 397-401.
6. Kern WV, Steinke P, Schumacher A et al. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 2006; 57: 339-43.
7. Pillai SK, Sakoulas G, Wennersten C et al. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis 2002; 186: 1603-7.
8. Schumacher A, Trittler R, Bohnert JA et al. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother 2007; 59: 1261-4.
9. Livermore DM, Warner M, Mushtaq S et al. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci. Antimicrob Agents Chemother 2007; 51: 1112-4.
10. Besier S, Ludwig A, Zander J et al. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother 2008; 52: 1570 2.